SCHEMBL1882295

SCHEMBL1882295

CCCCCCCCCCC(N)CCCC(=O)O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.79
FFAR4 Q5NUL3 2/20 0.63
FFAR1 O14842 2/20 0.63
GPR84 Q9NQS5 7/20 0.61
PPARG P37231 7/20 0.61
PPARD Q03181 7/20 0.61
PPARA Q07869 7/20 0.61
HDAC11 Q96DB2 5/20 0.61
TSHR P16473 4/20 0.61
PTPN1 P18031 3/20 0.61
TLR2 O60603 2/20 0.61
TDP1 Q9NUW8 2/20 0.61
FABP4 P15090 2/20 0.61
SLC22A6 Q4U2R8 1/20 0.61
SLC22A8 Q8TCC7 1/20 0.61
MEN1 O00255 1/20 0.61
ESR1 P03372 1/20 0.61
ALOX15 P16050 1/20 0.61
PDE4A P27815 1/20 0.61
KMT2A Q03164 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1878493 1.00 ALDH1A1 (0.79) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL5186949 1.00 ALDH1A1 (0.79) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL1876080 1.00 ALDH1A1 (0.79) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL1879962 1.00 ALDH1A1 (0.79) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL1877327 1.00 ALDH1A1 (0.79) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL1880419 0.98 ALDH1A1 (0.75) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL1878614 0.96 ALDH1A1 (0.85) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL1882232 0.96 ALDH1A1 (0.85) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL1879946 0.96 ALDH1A1 (0.85) ALDH1A1FFAR4FFAR1GPR84PPARG
SCHEMBL1884098 0.96 ALDH1A1 (0.85) ALDH1A1FFAR4FFAR1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3488000-A1 METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION INVISTA Textiles (U.K.) Limited (GB) 2019-05-29 EP disclosed
WO-2018022633-A1 METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION INVISTA TEXTILES (U.K.) LIMITED (GB) 2018-02-01 WO disclosed
US-20110105417-A1 Drug Conjugates THE CURATORS OF THE UNIVERSITY OF MISSOURI 2011-05-05 US disclosed
WO-2009158633-A1 DRUG CONJUGATES CURATORS OF THE UNIVERSITY OF MISSOURI ON BEHALF OF THE UNIVERSITY OF MISSOURI-KANSAS CITY (US) 2009-12-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105417-A1 Drug Conjugates ABCB1, SLCO2B1, ABCG2 ALDH1A1 660/4885FFAR4 368/4885FFAR1 374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.